Meta Pixel

News and Announcements

PromarkerD Shows Improved Predictive Ability & Robustness

  • Published December 15, 2016 3:19PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Proteomics International Laboratories Ltd (ASX: PIQ) is pleased to provide an update on its clinical studies for PromarkerD, the company’s breakthrough test for the prediction of diabetic kidney disease.

Highlights:

  • PromarkerD predicts diabetic kidney disease across all major clinical definitions of rapid decline in kidney function
  • Predictive ability improved – PromarkerD correctly predicted 61-97% of individuals who went on to have a clinically significant decline in kidney function within four years
  • Inter-laboratory study shows robustness of PromarkerD as a future Laboratory Developed Test

There are currently 415 million adults worldwide with diabetes, and approximately one third of these people have chronic kidney disease which can lead to dialysis or kidney transplant.

To read the full announcements please click on the button below.

Capital Insights
Where’s the beef? Blackstone just answered the AI question.

In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]

Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation

For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]

Join over 45,000+ sophisticated investors

Join Now